Your browser doesn't support javascript.
loading
Elevation of Anticancer Drug Toxicity by Caffeine in Spheroid Model of Human Lung Adenocarcinoma A549 Cells Mediated by Reduction in Claudin-2 and Nrf2 Expression.
Eguchi, Hiroaki; Kimura, Riho; Onuma, Saki; Ito, Ayaka; Yu, Yaqing; Yoshino, Yuta; Matsunaga, Toshiyuki; Endo, Satoshi; Ikari, Akira.
Affiliation
  • Eguchi H; Laboratory of Biochemistry, Department of Biopharmaceutical Sciences, Gifu Pharmaceutical University, Gifu 501-1196, Japan.
  • Kimura R; Laboratory of Biochemistry, Department of Biopharmaceutical Sciences, Gifu Pharmaceutical University, Gifu 501-1196, Japan.
  • Onuma S; Laboratory of Biochemistry, Department of Biopharmaceutical Sciences, Gifu Pharmaceutical University, Gifu 501-1196, Japan.
  • Ito A; Laboratory of Biochemistry, Department of Biopharmaceutical Sciences, Gifu Pharmaceutical University, Gifu 501-1196, Japan.
  • Yu Y; Laboratory of Biochemistry, Department of Biopharmaceutical Sciences, Gifu Pharmaceutical University, Gifu 501-1196, Japan.
  • Yoshino Y; Laboratory of Biochemistry, Department of Biopharmaceutical Sciences, Gifu Pharmaceutical University, Gifu 501-1196, Japan.
  • Matsunaga T; Laboratory of Bioinformatics, Gifu Pharmaceutical University, Gifu 502-8585, Japan.
  • Endo S; Laboratory of Biochemistry, Department of Biopharmaceutical Sciences, Gifu Pharmaceutical University, Gifu 501-1196, Japan.
  • Ikari A; Laboratory of Biochemistry, Department of Biopharmaceutical Sciences, Gifu Pharmaceutical University, Gifu 501-1196, Japan.
Int J Mol Sci ; 23(24)2022 Dec 07.
Article de En | MEDLINE | ID: mdl-36555089

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Adénocarcinome pulmonaire / Tumeurs du poumon / Antinéoplasiques Type d'étude: Prognostic_studies Limites: Humans Langue: En Journal: Int J Mol Sci Année: 2022 Type de document: Article Pays d'affiliation: Japon Pays de publication: Suisse

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Adénocarcinome pulmonaire / Tumeurs du poumon / Antinéoplasiques Type d'étude: Prognostic_studies Limites: Humans Langue: En Journal: Int J Mol Sci Année: 2022 Type de document: Article Pays d'affiliation: Japon Pays de publication: Suisse